TAYEBATI, Seyed Khosrow
 Distribuzione geografica
Continente #
NA - Nord America 21.989
EU - Europa 13.024
AS - Asia 12.709
SA - Sud America 1.324
AF - Africa 349
Continente sconosciuto - Info sul continente non disponibili 47
OC - Oceania 40
Totale 49.482
Nazione #
US - Stati Uniti d'America 21.031
CN - Cina 4.948
SG - Singapore 3.146
RU - Federazione Russa 2.916
IT - Italia 2.588
HK - Hong Kong 2.063
PL - Polonia 1.770
BR - Brasile 1.104
FR - Francia 1.069
UA - Ucraina 1.051
DE - Germania 1.041
VN - Vietnam 855
CA - Canada 780
SE - Svezia 776
GB - Regno Unito 597
FI - Finlandia 511
TR - Turchia 434
KR - Corea 419
IE - Irlanda 251
ZA - Sudafrica 231
IN - India 206
MX - Messico 124
NL - Olanda 113
BD - Bangladesh 78
AR - Argentina 73
IQ - Iraq 69
JP - Giappone 66
IR - Iran 63
PK - Pakistan 62
CH - Svizzera 54
CZ - Repubblica Ceca 54
EU - Europa 44
ID - Indonesia 41
ES - Italia 40
AU - Australia 34
EC - Ecuador 33
BE - Belgio 32
MA - Marocco 31
GR - Grecia 29
UZ - Uzbekistan 29
SA - Arabia Saudita 28
CO - Colombia 26
PE - Perù 24
TW - Taiwan 23
AT - Austria 20
LT - Lituania 20
MY - Malesia 20
VE - Venezuela 19
CL - Cile 18
EG - Egitto 18
PH - Filippine 17
AE - Emirati Arabi Uniti 16
RO - Romania 15
IL - Israele 14
TH - Thailandia 14
AZ - Azerbaigian 13
PY - Paraguay 13
DZ - Algeria 12
JO - Giordania 12
TN - Tunisia 12
JM - Giamaica 11
AL - Albania 10
EE - Estonia 10
KZ - Kazakistan 10
UY - Uruguay 10
DK - Danimarca 9
NP - Nepal 9
HU - Ungheria 8
PA - Panama 8
GH - Ghana 7
KE - Kenya 7
KG - Kirghizistan 7
NG - Nigeria 7
NO - Norvegia 7
RS - Serbia 7
TT - Trinidad e Tobago 7
CR - Costa Rica 6
LB - Libano 6
PT - Portogallo 6
DO - Repubblica Dominicana 5
GE - Georgia 5
GT - Guatemala 5
HN - Honduras 5
NZ - Nuova Zelanda 5
OM - Oman 5
BO - Bolivia 4
GA - Gabon 4
LV - Lettonia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
AM - Armenia 3
AO - Angola 3
CM - Camerun 3
CY - Cipro 3
ET - Etiopia 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AD - Andorra 2
Totale 49.441
Città #
Jacksonville 2.194
Hong Kong 2.040
Ashburn 1.741
Warsaw 1.571
Singapore 1.480
Fairfield 1.321
San Jose 1.261
Chandler 1.229
Woodbridge 1.162
Boardman 1.014
Houston 906
Wilmington 784
Beijing 658
Ann Arbor 626
Seattle 595
Nanjing 585
Toronto 560
The Dalles 496
Cambridge 448
Seoul 372
Los Angeles 363
Tongling 348
Istanbul 339
Lawrence 336
Princeton 336
San Mateo 331
Columbus 307
Shanghai 305
Lauterbourg 301
Camerino 292
Helsinki 290
Ogden 271
Ho Chi Minh City 264
New York 249
Dearborn 240
Dublin 235
St Louis 233
Nanchang 223
Dallas 212
Johannesburg 205
Centro 188
Guangzhou 181
Buffalo 162
Dong Ket 160
Moscow 160
Trieste 156
Hanoi 146
Kraków 146
Zhengzhou 146
Jiaxing 134
Milan 126
Shenyang 119
Kunming 115
Lachine 112
London 109
Düsseldorf 107
Orem 107
São Paulo 105
Santa Clara 103
Munich 101
Chicago 97
Tianjin 94
Hebei 90
Redondo Beach 89
Rome 88
Philadelphia 79
Bremen 76
Council Bluffs 76
Frankfurt am Main 71
Wuhan 71
Redwood City 69
Changsha 65
Chennai 60
Hangzhou 59
Tokyo 59
San Diego 56
Jinan 54
Vinnytsia 54
Denver 52
Rio de Janeiro 52
Montreal 50
Mexico City 48
Atlanta 45
Basingstoke 45
Falls Church 45
Kocaeli 44
Hefei 42
Manchester 40
Norwalk 40
Shenzhen 39
Brooklyn 38
Stockholm 38
Lanzhou 36
Phoenix 36
Mumbai 35
Orange 34
Verona 34
Detroit 33
Venezia 33
Wuxi 31
Totale 31.603
Nome #
Modified expression of peripheral blood lymphocyte muscarinic cholinergic receptors in asthmatic children. 1.199
Effetti neuroprotettivi del Nerve Growth Factor somministrato come collirio in bambini e giovani adulti con deficits visivi indotti da gliomi delle vie ottiche 725
A multidisciplinary approach to study the brain injury in Diet-Induced (DIO) rats 498
Metabolic effects of tart Cherries Supplementation in an animal model of obesity 464
Anatomia del Gray, I Fondamenti 399
Neurological Disorder, Stroke: Relevance of Preclinical Studies 367
Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain 364
Effects of Tart Cherry supplementation in Diet-Induced Obesity (DIO) rats. 355
Obesity-related nervous system injury: preliminary evidences in diet induced obesity (DIO) rats. 345
Effect of treatment with the antioxidant alpha-lipoic (thioctic) acid on heart and kidney microvasculature in spontaneously hypertensive rats 334
Telerehabilitation: Review of the State-of-the-Art and Areas of Application 320
Neuroinflammatory Markers in Spontaneously Hypertensive Rat Brain: An Immunohistochemical Study 315
Obesity affects central nervous system: a multidisciplinary study in Diet-Induced Obesity (DIO) rats 315
EXPRESSION OF SINAPTO-VESICULAR PROTEINS IN BRAIN AREAS OF AN ANIMAL MODEL OF METABOLIC SYNDROME 311
Frontiers in Molecular Biosciences 309
Process mining case study approach: Extraction of unconventional event logs to improve performance in Hospital Information Systems (HIS) 297
Identification of World Health Organisation ship's medicine chest contents by Anatomical Therapeutic Chemical (ATC) classification codes. 293
THE OBESE ZUCKER RATS: AN IN VIVO MODEL FOR STUDYING THE LIVER CARBONIC ANHYDRASE CAVII BIOLOGICAL ROLE 283
Brain alterations in high fat diet induced obesity: Effects of tart cherry seeds and juice 263
Brain Activity of Thioctic Acid Enantiomers: In Vitro and in Vivo Studies in an Animal Model of Cerebrovascular Injury 256
Adrenergic receptor subtypes in human peripheral blood lymphocytes. 248
Comparative analysis of the medicinal compounds of the ship's "medicine chests" in European Union maritime countries. Need for improvement and harmonization 247
Astrogliosis in the brain of obese Zucker rat: a model of metabolic syndrome. 246
Guida alla Farmacia di Bordo 241
Editorial Board of Neurosurgery Cases and Reviews 241
Age-related changes of dopamine receptors in the rat hippocampus: a light microscope autoradiography study. 241
Comparative machine-learning approach: A follow-up study on type 2 diabetes predictions by cross-validation methods 239
OBESITY-RELATED CEREBROVASCULAR INJURY IN OBESE ZUCKER RATS 237
Effects of acetylcholine precursors on inflammation in rat brain 235
Hypotensive effect of intravenous injection of tachykinins in conscious, freely moving spontaneously hypertensive and Wistar Kyoto rats. 234
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 234
Report on market analysis and preventions need to provide medications for rural patients of Italy using ICT technologies 231
PROTECTIVE ACITIVITY OF THE CHOLINE CONTAINING PHOSPHOLIPID CHOLINE ALPHOSCERATE, ON CEREBROVASCULAR TREE OF SPONTANEOUSLY HYPERTENSIVE RATS 230
Cerebrovascular and blood-brain barrier morphology in spontaneously hypertensive rats: effect of treatment with choline alphoscerate. 227
A novel clinical syndrome revealing a deficiency of the muscarinic M3 receptor. 226
Discovery of Highly Selective Imidazoline Receptor Ligands 222
Vesicular acetylcholine transporter (VAChT) in the brain of spontaneously hypertensive rats (SHR): effect of treatment with an acetylcholinesterase inhibitor 221
ACETYLCHOLINE PRECURSORS ATTENUATE NEUROINFLAMMATION IN LPS-STIMULATED BV2 CELLS 220
(Neuro)transmitter systems in circulating immune cells: a target of immunopharmacological interventions? 218
THE PHARMACIST KNOWLEDGE AND COMPUTER SKILLS TOWARDS E-HEALTH. RESULTS OF A SURVEY AMONG ITALIAN COMMUNITY PHARMACISTS 218
Effects of Prunus cerasus L. Seeds and Juice on Liver Steatosis in an Animal Model of Diet-Induced Obesity 218
Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes 214
ACTIVITY OF THIOCTIC ACID ENANTIOMERS ON SPINAL CORD CHANGES CONSEQUENT TO PERIPHERAL NERVE INJURY 213
Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook. 209
Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells 205
Ein neues klinisches Syndrom bedingt durch eine Defizienz des muskarinergen M3-Rezeptors: Trias aus bilateraler Mydriasis, Blasenentleerungsstörung und schlankem Habitus 205
Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodide 205
Age-related changes in the brain of obese Zucker rat: Morphological and immunochemical analysis. 205
Brain cholinergic dysfunction in obese Zucker LEPR(fa/fa) rats 204
Obesity-related blood brain barrier changes in obese Zucker rats 202
Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission 197
Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptors 197
Dementias and cognitive disorders: New insights and approaches 195
Age-related changes of muscarinic cholinergic receptor subtypes in the striatum of Fisher 344 rats. 194
Policies and challenges on the distribution of specialists and subspecialists in rural areas of Iran 194
Localization of the m5 muscarinic cholinergic receptor in rat circle of Willis and pial arteries 192
ACTIVITY OF CHOLINE ALPHOSCERATE ON CEREBROVASCULAR MORPHOLOGY AND INFLAMMATORY MARKERS IN SPONTANEOUSLY HYPERTENSIVE RATS 192
Occupancy by oral administration of nicardipine of L-type calcium channels in rat brain 191
Heart morphology in Zucker-obese rats 191
Cardiovascular changes related to metabolic syndrome: Evidence in obese zucker rats 188
Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds 188
ALLA SCOPERTA DEL RUOLO DELL’INVECCHIAMENTO E DEL SESSO NEI PROCESSI DEGENERATIVI FISIOLOGICI E PATOLOGICI DEI NERVI PERIFERICI. 187
Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes 187
Muscarinic Thioligands with Cyclopentane Nucleus 187
Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats. 186
Changes in muscarinic cholinergic receptor expression in human peripheral blood lymphocytes in allergic rhinitis patients. 184
Dopamine and vascular dynamics control: present status and future perspectives. 183
Obesity and Metabolic Syndrome Affects the Cholinergic Transmission and Cognitive Functions 182
Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction. 181
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 181
Synthesis, Absolute Configuration, and Biological Profile of the Enantiomers of trans-[2-(2,6-Dimethoxypheoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (Mephendioxan), a Potent Competitive alpha 1A-Adrenoreceptor Antagonist 179
Age-related Changes in the Density of Muscarinic Cholinergic M1 and M2 Receptor Subtypes in Pyramidal Neurons or the rat Hippocampus 179
Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands 178
Postnatal development of dopamine D1-like and D2-like receptors in the rat kidney: a radioligand binding study 177
Animal models of cognitive dysfunction. 177
Anti-Inflammatory and Antioxidant Properties of Tart Cherry Consumption in the Heart of Obese Rats 176
Potential dopamine-1 receptor stimulation in hypertension management. 176
TREATMENT WITH A CHOLINERGIC PRECURSOR IN AN ANIMAL MODEL OF CEREBROVASCULAR DISEASE: INSIGHTS INTO MECHANISMS OF NEUROPROTECTIVE ACTIVITY 176
Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. 175
Member of SCIENTIFIC ADVISORY BOARD of 9th International Congress on Vascular Dementia 175
Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study 174
Evaluation of an Agonist Index: Affinity Ratio for Compounds Active on Muscarinic Cholinergic M2 Receptors 174
Glial fibrillary acidic protein and vimentin expression is regulated by glucocorticoids and neurotrophic factors in primary rat astroglial cultures 173
Spontaneously hypertensive rat as a model of vascular brain disorder: Microanatomy, neurochemistry and behavior. 173
Influence of dermal exposure to the pyrethroid insecticide deltamethrin on rat brain microanatomy and cholinergic/dopaminergic neurochemistry. 173
Dopamine receptors in human platelets. 172
Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain. 172
BRAIN MORPHOLOGICAL ANALYSIS OF OBESE ZUCKER RAT: MODEL OF METABOLIC SYNDROME. 171
Choline-containing phospholipids: relevance to brain functional pathways. 170
Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity 170
Muscarinic cholinergic receptors subtypes in rat cerebellar cortex: light microscope autoradiography of age-related changes 169
Muscarinic cholinergic receptor subtypes in cerebral cortex of Fisher 344 rats: a light microscope autoradiography study of age-related changes. 169
Modulation Of Monoaminergic Transporters By Choline-Containing Phospholipids In Rat Brain. 169
ALPHA1-ADRENERGIC RECEPTOR SUBTYPES HUMAN PERIPHERAL BLOOD LYMPHOCYTES 168
Identification of adenosine A1 and A3 receptor subtypes in rat pial and intracerebral arteries. 168
Postnatal development of dopamine receptor expression in rat peripheral blood lymphocytes. 167
Does obesity affect the mucin secretion of the rat intestinal mucosa? 165
Heart Morphology in Zucker-Obese Rat 165
The dopaminergic system in hypertension 164
Alpha1-adrenergic receptor subtypes in peripheral blood lymphocytes of essential hypertensives 164
Totale 23.683
Categoria #
all - tutte 205.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.708 0 0 0 0 0 0 0 0 0 257 825 626
2021/20222.957 110 784 86 149 257 126 76 216 295 240 222 396
2022/20233.537 456 115 113 418 399 505 55 245 678 226 222 105
2023/20242.984 472 157 196 80 158 234 127 137 390 127 104 802
2024/202510.367 490 292 1.205 789 263 482 930 2.406 709 759 475 1.567
2025/202612.990 742 1.892 995 1.836 1.312 992 2.387 1.230 608 996 0 0
Totale 50.357